Joshua Meier was Chief AI Officer at Absci, where he spearheaded the company's transformation into AI Drug Discovery and built robust departments of top-tier AI scientists and engineers. Under Joshua’s leadership, Absci pioneered groundbreaking generative AI models for the creation of novel protein therapeutics, closed deals with leading biopharmaceutical companies and published work on zero-shot antibody design, antibody optimization, and codon optimization. Prior to Absci, Joshua was a senior researcher at Facebook AI Research, where he co-founded and led the platform for evolutionary-scale protein language modeling. At Facebook, Joshua was principal developer of the ESM-1b and ESM-1v models, which are widely utilized across the biopharmaceutical industry. In his earlier roles, Joshua developed language models & reinforcement learning at OpenAI, managed a virtual reality product at Google, and built MIT's CRISPR-ML design platform. Joshua completed his undergraduate and graduate work in computer science & chemistry at Harvard.